Dr Khalid Al-Rasadi, MD - Medical Research Center at Sultan Qaboos University  - Associate Professor

Dr Khalid Al-Rasadi

MD

Medical Research Center at Sultan Qaboos University

Associate Professor

Muscat, Oman | Oman

Main Specialties: Biochemical Genetics, Cardiovascular Disease

Additional Specialties: Lipidology

ORCID logohttps://orcid.org/0000-0003-0460-1236


Top Author

Dr Khalid Al-Rasadi, MD - Medical Research Center at Sultan Qaboos University  - Associate Professor

Dr Khalid Al-Rasadi

MD

Introduction

Dr. Khalid Al Rasadi was born in Oman where he studied medicine and obtained his Medical Degree in 1998. Dr. Al Rasadi obtained his postgraduate training in Medical Biochemistry at McGill University in Canada during 2002-2006. He spent another two years in Canada, working as scientist at the Royal Victoria Hospital, McGill University, under the supervision of Prof. Jacques Genest. There he performed a number of studies on the molecular genetics of familial hypercholesterolemia and hypoalphalipoproteinemia. In that period Dr. Al Rasadi also received training at the lipid clinic of the Royal Victoria Hospital, McGill University. He was also awarded a certificate in Clinical Lipidology by the National Lipid Association in the United State in 2008.
Dr. Al Rasadi is Associate Professor, the Head of Department of Biochemistry at the Sultan Qaboos University in Oman and head of lipid and LDL-Apheresis unit at Sultan Qaboos University Hospital. He is one of the founder members of the Oman Society of Lipid and Atherosclerosis (OSLA) and its current President. He is also the founder of the Arab States of the Gulf (GCC) Familial Hypercholesterolemia Foundation and its current President. He contributed significantly to the recognition of OSLA as an active society nationally and internationally by promoting meetings aimed at education and general awareness relating to lipid disorders and atherosclerosis. He organized conferences involving experts in the field of lipid research. His activities include public outreach meetings in Oman. International collaboration has also been initiated via OSLA. OSLA has received the IAS-Pfizer educational grant for the management of dyslipidemia in the Gulf region.
Dr. Al Rasadi is a member of national and international medical associations and a member of Oman Medical Journal and BBA-Clinical Journal editorial board. Dr Al-Rasadi is an Editor in-Chief, OSLA section in the Open Cardiovascular Medicine Journal. He is an International Atherosclerosis Society (IAS) executive board member and assessor for Fellowships. He has around 68 publications and 1 chapter book (total Citations 949, H-Index: 12).



Primary Affiliation: Medical Research Center at Sultan Qaboos University - Muscat, Oman , Oman

Specialties:

Additional Specialties:

Research Interests:


View Dr Khalid Al-Rasadi’s Resume / CV

Education

Jun 2008
National Lipid
American Board Of Clinical Lipidology
Jun 2006
Royal College of Physicians and Surgeons of Canada, McGill University, Montreal, Canada.
FRCPC in Medical Biochemistry
May 1998
Sultan Qaboos University
MD

Experience

Jan 2020
The OMAN study on the impact of lipoprotein(a) levels in HEalthy controls and patients with premature acute coronary ARTery syndrome (OMANHEART) Study
PI
Jan 2019
OMAN cascade screening to prevent early Onset Risk of cardiovascular diseases in familial hypercholesterolemia Young children and adult indeX cases and their families (OMANORYX) Study
PI
Feb 2017
The Gulf Familial Hypercholesterolemia Registry (Gulf FH)
PI

Publications

75Publications

3183Reads

2Profile Views

Anti-fibrotic effects of curcumin and some of its analogues in the heart.

Heart Fail Rev 2020 Sep;25(5):731-743

Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10741-019-09854-6
Publisher Site
http://dx.doi.org/10.1007/s10741-019-09854-6DOI Listing
September 2020
2 Reads
3.787 Impact Factor

Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study.

J Clin Lipidol 2019 Jul - Aug;13(4):594-600. Epub 2019 May 14.

Lipid Clinic, Heart Institute (InCor), University of Sao Paulo Medical School Hospital and Hospital Israelita Albert Einstein, Sao Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2019.05.004DOI Listing
June 2020
14 Reads

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.

JAMA Cardiol 2020 Jan 2. Epub 2020 Jan 2.

Familial Hypercholesterolemia Foundation, Pasadena, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2019.5173DOI Listing
January 2020

Diabetes and Mortality in Acute Coronary Syndrome: Findings from the Gulf COAST Registry.

Curr Vasc Pharmacol 2020 ;18(1):68-76

Department of Medicine, Ministry of Health, Al-Adan, Kuwait.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1570161116666181024094337DOI Listing
January 2020
54 Reads
2.966 Impact Factor

The Incidence of Adverse Drug Reactions in Patients Treated with Statins in the Emirates: A Retrospective Cohort Study.

Curr Vasc Pharmacol 2020 ;18(2):193-199

Department of Internal Medicine, United Arab Emirates University, College of Medicine and Health Sciences, Al Ain, United Arab Emirates.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1570161117666190408164908DOI Listing
January 2020
5 Reads
2.966 Impact Factor

Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis.

Arch Med Sci 2019 Oct 3;15(6):1365-1374. Epub 2019 Nov 3.

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2019.89450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855171PMC
October 2019
1.890 Impact Factor

Use of cardiovascular risk scores in acute coronary syndrome patients with familial hypercholesterolemia.

J Clin Lipidol 2018 Sep - Oct;12(5):1329. Epub 2018 Jul 10.

Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.07.001DOI Listing
September 2019

Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.

J Clin Lipidol 2018 May - Jun;12(3):685-692.e2. Epub 2018 Feb 14.

Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait city, Kuwait.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.02.003DOI Listing
September 2019
111 Reads

Dietary natural products as emerging lipoprotein(a)-lowering agents.

J Cell Physiol 2019 08 13;234(8):12581-12594. Epub 2019 Jan 13.

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.28134DOI Listing
August 2019
27 Reads
3.839 Impact Factor

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Cardiovasc Diabetol 2019 06 4;18(1):71. Epub 2019 Jun 4.

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12933-019-0864-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549355PMC
June 2019
14 Reads
4.015 Impact Factor

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

Atherosclerosis 2018 10;277:234-255

Imperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2018.08.051DOI Listing
October 2018
28 Reads
3.994 Impact Factor

PCSK9 and infection: A potentially useful or dangerous association?

J Cell Physiol 2018 04 4;233(4):2920-2927. Epub 2017 Jul 4.

Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.26040DOI Listing
April 2018
74 Reads
3.839 Impact Factor

Natural approaches in metabolic syndrome management.

Arch Med Sci 2018 Mar 19;14(2):422-441. Epub 2017 Jul 19.

CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2017.68717DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868676PMC
March 2018
13 Reads
1.890 Impact Factor

Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study.

Lipids Health Dis 2018 Feb 5;17(1):25. Epub 2018 Feb 5.

Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao, Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12944-018-0667-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800019PMC
February 2018
27 Reads
2.219 Impact Factor

Improvement of endothelial function by pitavastatin: a meta-analysis.

Expert Opin Pharmacother 2018 Feb 18;19(3):279-286. Epub 2018 Jan 18.

g Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences , Mashhad , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2018.1428560DOI Listing
February 2018
54 Reads
3.534 Impact Factor

New Treatments on the Horizon for Familial Hypercholesterolemia.

Oman Med J 2017 Nov;32(6):447-448

Department of Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5001/omj.2017.86DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702991PMC
November 2017
12 Reads

World Heart Federation Cholesterol Roadmap.

Glob Heart 2017 09 29;12(3):179-197.e5. Epub 2017 Jul 29.

World Heart Federation, Geneva, Switzerland; Department of Cardiovascular Medicine, Imperial College London, London, United Kingdom; National Heart and Lung Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gheart.2017.03.002DOI Listing
September 2017
33 Reads

Lipoprotein (a) and Cardiovascular Risk: The Show Must go on.

Curr Med Chem 2017 ;24(10):989-1006

Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital campus, University College London Medical School, University College London (UCL), Pond Street, London NW3 2QG, United Kingdom.

View Article

Download full-text PDF

Source
http://www.eurekaselect.com/node/149191/article
Publisher Site
http://dx.doi.org/10.2174/0929867324666170112111948DOI Listing
July 2017
3 Reads
3.853 Impact Factor

Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia.

Can J Cardiol 2017 05 10;33(5):658-665. Epub 2017 Feb 10.

Research Institute of the McGill University Health Centre, Montreal, Québec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2017.02.001DOI Listing
May 2017
54 Reads
3.711 Impact Factor

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

Atheroscler Suppl 2016 Dec 7;22:1-32. Epub 2016 Dec 7.

Imperial Centre for Cardiovascular Disease Prevention (ICCP), School of Public Health, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosissup.2016.10.001DOI Listing
December 2016
198 Reads
2.293 Impact Factor

Nutraceuticals as Lipid-Lowering Treatment in Pregnancy and Their Effects on the Metabolic Syndrome.

Curr Pharm Biotechnol 2016;17(7):614-23

Department of Clinical Biochemistry, Sultan Qaboos University Hospital, P.O. Box: 38, postal code 123, Muscat, Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389201017666160401145817DOI Listing
December 2016
58 Reads
2.511 Impact Factor

Incretins, Pregnancy, and Gestational Diabetes.

Curr Pharm Biotechnol 2016;17(7):597-602

Biomedical Department of Internal Medicine and Medical Specialties, School of Medicine, University of Palermo, Palermo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389201017666160127110125DOI Listing
December 2016
75 Reads
2.511 Impact Factor

Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East.

Int J Cardiol 2016 Dec 28;225:268-283. Epub 2016 Sep 28.

School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.09.081DOI Listing
December 2016
40 Reads
4.036 Impact Factor

The effect of bergamot on dyslipidemia.

Phytomedicine 2016 Oct 30;23(11):1175-81. Epub 2015 Dec 30.

Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; Euro-Mediterranean Institute of Science and Technology, Palermo, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phymed.2015.12.005DOI Listing
October 2016
36 Reads
3.126 Impact Factor

Dyslipidaemia in the Middle East: Current status and a call for action.

Atherosclerosis 2016 09 30;252:182-187. Epub 2016 Jul 30.

School of Medical Sciences, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.925DOI Listing
September 2016
31 Reads
3.994 Impact Factor

Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?

Atherosclerosis 2016 May 9;248:62-75. Epub 2016 Mar 9.

Department of Internal Medicine and Medical Specialties, University of Palermo, Italy; Euro-Mediterranean Institute of Science and Technology, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2016.02.018DOI Listing
May 2016
25 Reads
3.994 Impact Factor

Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study.

Expert Opin Biol Ther 2015 20;15(10):1391-7. Epub 2015 Jul 20.

a 1 University of South Carolina School of Medicine, Division of Endocrinology, Diabetes and Metabolism , Columbia, SC, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14712598.2015.10
Publisher Site
http://dx.doi.org/10.1517/14712598.2015.1067299DOI Listing
April 2016
27 Reads
3.743 Impact Factor

Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.

J Clin Lipidol 2015 Mar-Apr;9(2):187-94. Epub 2014 Nov 29.

Department of Clinical Biochemistry, King Abdulaziz University, Abdullah Sulayman, Jeddah, Saudi Arabia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2014.11.008DOI Listing
January 2016
54 Reads

Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome.

Angiology 2015 Oct 27;66(9):856-61. Epub 2015 Jan 27.

Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0003319714568792
Publisher Site
http://dx.doi.org/10.1177/0003319714568792DOI Listing
October 2015
54 Reads
2.370 Impact Factor

Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation.

Angiology 2015 Aug 6;66(7):601-3. Epub 2014 Nov 6.

Department of Clinical Biochemistry, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319714557353DOI Listing
August 2015
20 Reads
2.370 Impact Factor

The Effect of Residing Altitude on Levels of High-Density Lipoprotein Cholesterol: A Pilot Study From the Omani Arab Population.

Angiology 2015 Jul 29;66(6):568-73. Epub 2014 Jul 29.

Department of Clinical Biochemistry, College of Medicine & Health Sciences, Sultan Qaboos University Hospital, Muscat, Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319714544355DOI Listing
July 2015
27 Reads
2.370 Impact Factor

Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.

Hemoglobin 2014 30;38(5):365-8. Epub 2014 Jul 30.

Department of Hematology, Sultan Qaboos University Hospital , Muscat , Oman .

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/03630269.2014.94
Publisher Site
http://dx.doi.org/10.3109/03630269.2014.944314DOI Listing
June 2015
19 Reads
0.955 Impact Factor

Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan.

Angiology 2015 May 18;66(5):416-21. Epub 2014 Jul 18.

Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy Department of Population Health, Euro-Mediterranean Institute of Science and Technology, Palermo, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319714542999DOI Listing
May 2015
22 Reads
2.370 Impact Factor

Therapeutic lipid target achievements among high and highest risk patients: results from the CEPHEUS study in the Arabian Gulf.

Curr Med Res Opin 2014 Dec 29;30(12):2429-35. Epub 2014 Sep 29.

Department of Biochemistry, Sultan Qaboos University Hospital , Muscat , Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2014.965774DOI Listing
December 2014
50 Reads
2.653 Impact Factor

Reference values for arterial stiffness indices in an Omani Arab population.

Saudi Med J 2014 Nov;35(11):1367-72

Department of Physiology and Clinical Physiology, College of Medicine and Health Sciences, Sultan Qaboos University, PO Box 35, Postal Code 123, AlKhoud, Muscat, Sultanate of Oman. Fax. +968 24143514. E-mail.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362140PMC
November 2014
99 Reads
0.554 Impact Factor

Low-density lipoprotein receptor gene mutation analysis and structure-function correlation in an Omani arab family with familial hypercholesterolemia.

Angiology 2014 Nov 17;65(10):911-8. Epub 2013 Nov 17.

Department of Clinical Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman Familial Hypercholesterolemia Study Group, Oman Society of Lipid and Atherosclerosis (OSLA), Sultan Qaboos University, Muscat, Oman

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319713510059DOI Listing
November 2014
14 Reads
2.370 Impact Factor

Familial hypercholesterolaemia.

Curr Opin Cardiol 2014 Jul;29(4):381-8

aDepartment of Metabolic Medicine, Clinical Biochemistry, Royal Free NHS Foundation Trust, London, UK bDepartment of Clinical Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCO.0000000000000083DOI Listing
July 2014
16 Reads
2.696 Impact Factor

The effects of anti-diabetic drugs on LDL subclasses: any role for colesevelam?

Cardiovasc Drugs Ther 2014 Jun;28(3):205-7

Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Via del Vespro, 141, 90127, Palermo, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10557-014-6521-1DOI Listing
June 2014
22 Reads
3.189 Impact Factor

Treatment options for managing atherogenic dyslipidemia and fatty liver disease.

Expert Opin Pharmacother 2014 Jun 27;15(8):1065-8. Epub 2014 Mar 27.

University of Palermo, Biomedical Department of Internal Medicine and Medical Specialties , Palermo, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.902051DOI Listing
June 2014
1 Read
3.534 Impact Factor

Comparison of therapeutic lipid target achievements among high-risk patients in Oman.

Angiology 2014 May 5;65(5):430-5. Epub 2013 Apr 5.

1Department of Clinical Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319713482572DOI Listing
May 2014
27 Reads
2.370 Impact Factor

Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population.

Oman Med J 2014 Mar;29(2):85-91

Department of Clinical Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman; Department of Clinical Physiology, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5001/omj.2014.22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976735PMC
March 2014
35 Reads

Will β-blockers live up to the maxim of Sir James Black, their creator?

Angiology 2012 Aug;63(6):409-11

Department of Clinical Biochemistry, Sultan Qaboos University, Al-Khod, Muscat, Sultanate of Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003319711434636DOI Listing
August 2012
2 Reads
2.370 Impact Factor

Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.

N Engl J Med 2012 06;366(25):2425-6; author reply 2426

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMc1204929
Publisher Site
http://dx.doi.org/10.1056/NEJMc1204929DOI Listing
June 2012
5 Reads
55.873 Impact Factor

Benefits of lowering cholesterol in chronic kidney disease.

Lancet 2011 Oct;378(9800):1376-7; author reply 1377-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)61607-3DOI Listing
October 2011
45.217 Impact Factor

Prevalence, characteristics, and in-hospital outcomes of metabolic syndrome among acute coronary syndrome patients from Oman.

Angiology 2011 Jul;62(5):381-9

Department of Clinical Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman.

View Article

Download full-text PDF

Source
http://ang.sagepub.com/content/62/5/381.full.pdf
Web Search
http://ang.sagepub.com/cgi/doi/10.1177/0003319710382419
Publisher Site
http://dx.doi.org/10.1177/0003319710382419DOI Listing
July 2011
3 Reads
2.370 Impact Factor

Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman.

Curr Med Res Opin 2011 Apr 18;27(4):879-85. Epub 2011 Feb 18.

Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2011.559537DOI Listing
April 2011
6 Reads
2.653 Impact Factor

Top co-authors

Khalid Al-Waili
Khalid Al-Waili

Sultan Qaboos University

20
Yajnavalka Banerjee
Yajnavalka Banerjee

Sultan Qaboos University

16
Raul D Santos
Raul D Santos

Lipid Clinic Heart Institute (InCor)

16
Maciej Banach
Maciej Banach

Medical University of Lodz

14
Ali T Al-Hinai
Ali T Al-Hinai

Sultan Qaboos University

13
Manfredi Rizzo
Manfredi Rizzo

University of Palermo

13
Abdullah Shehab
Abdullah Shehab

United Arab Emirates University

11